tiprankstipranks
Panacea Life Sciences Holdings Inc (PLSH)
OTHER OTC:PLSH
US Market
Holding PLSH?
Track your performance easily

Panacea Life Sciences Holdings Inc (PLSH) Financial Statements

10 Followers

Panacea Life Sciences Holdings Inc Financial Overview

Panacea Life Sciences Holdings Inc's market cap is currently ―. The company's EPS TTM is $-0.347; its P/E ratio is -0.23; Panacea Life Sciences Holdings Inc is scheduled to report earnings on November 18, 2021, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.06M$ 960.50K$ 399.13K$ 677.48K$ 324.79K
Gross Profit$ 666.16K$ 546.93K$ 202.81K$ 1.13M$ 110.79K
EBIT$ -1.02M$ -1.80M$ -1.50M$ 2.52M$ -1.33M
EBITDA$ -632.90K$ -1.35M$ -1.07M$ -988.58K$ -690.14K
Net Income Common Stockholders$ -1.45M$ -2.21M$ -1.86M$ -1.79M$ -1.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 117.15K$ 115.86K$ 468.58K$ 998.34K$ 1.11M
Total Assets$ 17.41M$ 17.98M$ 17.85M$ 18.56M$ 19.49M
Total Debt$ 6.13M$ 6.28M$ 16.07M$ 15.62M$ 5.42M
Net Debt$ 6.01M$ 6.17M$ 15.60M$ 14.62M$ 4.31M
Total Liabilities$ 27.04M$ 26.27M$ 23.42M$ 22.36M$ 21.63M
Stockholders Equity$ -9.62M$ -8.29M$ -5.57M$ -3.80M$ -2.14M
Cash Flow-
Free Cash Flow$ -362.09K$ -16.33K$ -492.67K$ -329.07K$ -621.84K
Operating Cash Flow$ -357.09K$ 1.57K$ -483.32K$ -313.85K$ -523.00K
Investing Cash Flow$ -5.00K$ -17.91K$ -9.35K$ -15.22K$ -98.84K
Financing Cash Flow$ 368.81K$ 115.76K$ 427.62K$ 395.35K$ 592.00K
Currency in USD

Panacea Life Sciences Holdings Inc Earnings and Revenue History

Panacea Life Sciences Holdings Inc Debt to Assets

Panacea Life Sciences Holdings Inc Cash Flow

Panacea Life Sciences Holdings Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis